Table 2.
Management, outcome, symptoms and treatment of Covid-19 lung cancer patients.
| N | Percentage (%) | |
|---|---|---|
| Covid-19 diagnosis | ||
| Hospitalization admission | 13 | 76.4 |
| ICU admission | 0 | 0 |
| Home management (discharged from hospital at diagnosis) | 4 | 23.5 |
| Covid-19 outcome | ||
| Dead | 9 | 52.9 |
| Alive | 8 | 47.1 |
| Severe covid-19 infection | 11 | 64.7 |
| Symptoms | ||
| Fever | 12 | 70.6 |
| Cough | 17 | 100 |
| Myalgia | 5 | 29.4 |
| Dyspnea | 13 | 76.4 |
| Diarrhea | 1 | 5.9 |
| Covid-19 treatment | ||
| Lopinavir/ritonavir + Hydroxichloroquine | 2 | 11.7 |
| Hydroxichloroquine + azithromycin | 8 | 47.1 |
| Lopinavir/ritonavir + Hydroxichloroquine + azithromycin | 1 | 5.9 |
| Hydroxichloroquine | 1 | 5.9 |